Registered users may save selected Research Articles, Review Articles and Editorials to the My Articles area of My Virtual Journals.
Sort by: | Date
16 May 2008
The director of the PATH Malaria Vaccine Initiative is optimistic but says there is still a long way to go.
16 Apr 2008
When a sand fly transmits leishmania parasites it also injects biologically active salivary. It is a possibility that a vaccine that acted against the saliva might protect against leishamaniasis. In this study researchers found that one salivary protein protected while another exacerbated Leishmaniasis major infection, suggesting that the type of immune response induced by specific salivary proteins can prime and direct anti-leishmania immunity
Source: PLoS Neglected Tropical Diseases
PubMed Record |
19 Mar 2008
New findings may aid in the development of system for large-scale production of a dengue vaccine.
Source: PLoS ONE
PubMed Record |
2 Jan 2008
There is little doubt that effective interventions against Plasmodium vivax are needed. An estimated 2.6 billion people live in areas endemic for P. vivax, and P. vivax carries a substantial burden of disease with 50–70 million clinical episodes each year.
Source: PLoS Medicine
31 Oct 2007
The decade between initiation of the Mycobacterium leprae genome project and its final publication witnessed a progressive decline in interest in leprosy research.
19 Oct 2007
A trial of an antimalaria vaccine in Mozambique has found that it can be safely used in infants and shows promise in protecting them against infection.
19 Sep 2007
The Bill and Melinda Gates Foundation announced a new package of funding yesterday (18 September) to accelerate and build on existing technologies to combat tuberculosis (TB).
30 Jul 2007
Clinical trials of a new tuberculosis vaccine have begun in the Gambia and South Africa, announced UK funding body the Wellcome Trust last week (28 July).
Register for free
Forgot your password?
Is your organisation working against the infectious diseases of poverty?